may have noticed uh some of the pharmaceutical names have moved up sharply in the last few minutes. We've got some breaking news out of Washington on drug pricing. Aean Jabers has the details perhaps filling us in on why we've seen this move.Aean. Yeah, David. It is pharmaceutical related.Uh and we don't have all the details right now. We're trying to solve a mystery in real time here, which is that the president has an event on his calendar at 11:00 a. m.just scheduled as an announcement. Uh and the questi ...

Core Points - The announcement from the White House is related to pharmaceutical pricing, specifically involving a deal with a major pharmaceutical company [3][4][5] - The agreement reportedly includes discounted prices for Medicaid and a three-year reprieve on tariffs for products manufactured in the United States [3][5] - The company involved in the deal is speculated to be Pfizer, although this has not been officially confirmed by the White House [4][5][7] Pharmaceutical Industry Impact - The initiative aims to lower drug prices across the board, aligning with the president's goal to address pharmaceutical pricing as a significant issue during his presidency [5] - The program may be branded as "Trump RX," allowing consumers to purchase certain medications directly from a government website [6][7] - There is uncertainty regarding the participation of other pharmaceutical companies and the implications for individuals already on Medicare or Medicaid [7]

Core Viewpoint - Pfizer announced an acquisition of Metsera, offering $47.50 per share, with an additional $22.50 per share contingent on the achievement of specific drug milestones [1] Company Summary - Pfizer is set to pay a total of $70 per share for Metsera if certain performance milestones are met, indicating a strategic investment in Metsera's drug pipeline [1]

Market Initiatives - President Trump plans to unveil a direct-to-consumer website for Americans to buy drugs, dubbed TrumpRx [1] Pharmaceutical Pricing - Pfizer plans to lower prices on several of its medications in the US [1] Source of Information - White House press secretary Karoline Leavitt announced the plan on X [1]

President Donald Trump on Tuesday announces an agreement with Pfizer to voluntarily sell its medications at lower prices, as his administration pushes to link U.S. drug prices to the cheaper prices paid abroad. Pfizer CEO Albert Bourla will be in attendance, a White House official said. For access to live and exclusive video from CNBC subscribe to CNBC PRO: https://cnb.cx/42d859g » Subscribe to CNBC TV: https://cnb.cx/SubscribeCNBCtelevision » Subscribe to CNBC: https://cnb.cx/SubscribeCNBC » Watch CNBC on ...

Group 1 - Pfizer's CEO is expected to announce a $70 billion investment in drug production in the United States [1] - The White House will launch a drug purchasing website named "TRUMPRX" [1] - TRUMPRX will allow individuals to purchase certain drugs directly with cash through a government website, benefiting from government-negotiated discount prices [1]

Watch live coverage as President Trump announces a deal with Pfizer on lowering drug prices. For more context and news coverage of the most important stories of our day, click here: https://www.nbcnews.com » Subscribe to NBC News: http://nbcnews.to/SubscribeToNBC » Watch more NBC video: http://bit.ly/MoreNBCNews NBC News Digital is a collection of innovative and powerful news brands that deliver compelling, diverse and engaging news stories. NBC News Digital features NBCNews.com, MSNBC.com, TODAY.com, Night ...

Group 1 - President Donald Trump will announce that Pfizer plans to lower prices on several of its medications in the United States [1]

Core Points - President Trump is set to announce a deal with Pfizer to voluntarily lower drug prices, linking U.S. prices to those paid abroad [1][2] - The announcement will take place at 11 a.m. ET, with Pfizer CEO Albert Bourla in attendance [2] - Trump previously sent letters to Pfizer and 16 other drugmakers urging them to lower drug prices by September 29, following the revival of the "most favored nation" policy aimed at reducing costs [3]

Group 1 - Pfizer's stock price increased by over 2.3%, reaching $24.4 [1] - President Trump announced a drug pricing agreement with Pfizer, allowing the company to voluntarily sell its drugs at lower prices through the Medicaid program [1]